You are here

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them

Authors

  1. Correspondence to : Professor Eli Schwartz, The Chaim Sheba Medical Center, The Center for Geographic Medicine, Tel Hashomer 52621, Israel; elischwa{at}post.tau.ac.il
View Full Text

Citation

Schwartz E, Lachish T
Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them
BMJ Evidence-Based Medicine 2016;21:64.

Publication history

  • First published January 12, 2016.
Online issue publication 
May 26, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/